Depression Studies Reveal Similar Treatment Patterns in the UK and US
January 10, 2000 Depression Studies Reveal Similar Treatment Patterns in the UK and US United Kingdom patients whose depression is treated with selective serotonin reuptake inhibitors (SSRIs) remain on therapy longer and are more likely to receive doses as recommended in clinical guidelines than patients treated with tricyclic antidepressants (TCAs), according to a study by The MEDSTAT Group. These results mirror the findings of several other studies conducted by MEDSTAT using data from the United States. "Stability of antidepressant use patterns is important because patients with stable therapy may experience more favorable clinical and economic outcomes than patients who have . . .
